Salivary gland adenoid cystic carcinoma
MONDO:0003175An adenoid cystic carcinoma arising from the salivary gland. It is characterized by the presence of epithelial and myoepithelial cells forming tubular, cribriform, and solid patterns. It usually presents as a slow growing mass. Patients may experience pain because of the tumor propensity for perineural invasion. The tumor may follow an aggressive clinical course with recurrences and mestastases to distant sites including lungs, bones, brain, and liver.
Also known as: adenoid cystic cancer, adenoid cystic carcinoma (morphologic abnormality), adenoid cystic carcinoma of salivary gland, adenoid cystic carcinoma of the salivary gland, cylindroma (morphologic abnormality), saliva-secreting gland adenoid cystic carcinoma, salivary gland adenoid cystic cancer, salivary gland adenoid cystic carcinoma
2975 clinical trials for this condition and its sub-types, 3 tagged with Salivary gland adenoid cystic carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Salivary gland adenoid cystic carcinoma
-
3 sub-types
-
Scientists hunt for clues in blood and tumors to predict Cancer's next move
Knowledge-focused Recruiting nowThis observational study aims to understand why metastatic adenoid cystic carcinoma (ACC) of the head and neck behaves differently in different people. Researchers will analyze stored tumor tissue and blood samples from 114 adults to see if certain biological types (ACC-I or ACC-…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Microchip implant could personalize cancer drug selection
Knowledge-focused Recruiting nowThis early-phase study is testing a small implantable device that delivers tiny amounts of different drugs directly into head and neck tumors. The goal is to see which drugs are most effective for each person before they undergo full treatment. The study involves 30 adults with c…
Early phase 1 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC